A
Attunepharma
attunepharma.com
Website unreachable since Oct 26, 2026
The startup develops orally administered small molecule therapeutics and heterocyclic derivative compounds specifically for treating hereditary angioedema and other rare diseases. By providing targeted pharmaceutical compositions, the company enables clinicians to effectively manage and treat these challenging medical conditions.
Traction –/10
City of New York, United States · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops orally administered small molecule therapeutics and heterocyclic derivative compounds specifically for treating hereditary angioedema and other rare diseases. By providing targeted pharmaceutical compositions, the company enables clinicians to effectively manage and treat these challenging medical conditions.